Logo Logo

Publications by Appelboom, T.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 2.

Journal article

Heldmann, F.; Baraliakos, X.; Kiltz, U.; Brandt, J.; Horst-Bruinsma, I. E. van der; Landewe, R.; Sieper, J.; Burmester, G. R.; Bosch, F. van den; Vlam, K. de; Gaston, H.; Gruenke, M.; Witt, M.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Braun, J. (2016): Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety. In: Clinical and Experimental Rheumatology, Vol. 34, No. 2: pp. 184-190

Baraliakos, X.; Heldmann, F.; Callhoff, J.; Listing, J.; Appelboom, T.; Brandt, J.; Bosch, Frank van den; Breban, M.; Burmester, G. R.; Dougados, M.; Emery, P.; Gaston, H.; Grunke, M.; Horst-Bruinsma, I. E. van der; Landewe, R.; Leirisalo-Repo, M.; Sieper, J.; De Vlam, K.; Pappas, D.; Kiltz, U.; Heijde, D. van der; Braun, J. (October 2014): Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. In: Annals of the rheumatic diseases, Vol. 73, No. 10: pp. 1819-1825 [PDF, 2MB]

This list was generated on Mon Nov 23 18:26:56 2020 CET.